Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 183
of 10Next
1:

Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro.

Unni E, Koul D, Yung WK, Sinha R.

Breast Cancer Res. 2005;7(5):R699-707. Epub 2005 Jul 6.

PMID: 16168115 [PubMed - indexed for MEDLINE]

2:

Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells.

Sinha R, Kiley SC, Lu JX, Thompson HJ, Moraes R, Jaken S, Medina D.

Cancer Lett. 1999 Nov 15;146(2):135-45.

PMID: 10656618 [PubMed - indexed for MEDLINE]

3:

Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine.

Unni E, Kittrell FS, Singh U, Sinha R.

Breast Cancer Res. 2004;6(5):R586-92. Epub 2004 Jul 29.

PMID: 15318939 [PubMed - indexed for MEDLINE]

4:

Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells.

Sinha R, Medina D.

Carcinogenesis. 1997 Aug;18(8):1541-7.

PMID: 9276628 [PubMed - indexed for MEDLINE]

5:

Se-methylselenocysteine activates caspase-3 in mouse mammary epithelial tumor cells in vitro.

Unni E, Singh U, Ganther HE, Sinha R.

Biofactors. 2001;14(1-4):169-77.

PMID: 11568454 [PubMed - indexed for MEDLINE]

6:

The mitogen-activated protein kinase pathway tonically inhibits both basal and IGF-I-stimulated IGF-binding protein-5 production in mammary epithelial cells.

Fleming JM, Brandimarto JA, Cohick WS.

J Endocrinol. 2007 Aug;194(2):349-59.

PMID: 17641284 [PubMed - indexed for MEDLINE]

7:

Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland.

Ip C, Thompson HJ, Ganther HE.

Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):49-54.

PMID: 10667463 [PubMed - indexed for MEDLINE]

8:

Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways.

Sinha R, Said TK, Medina D.

Cancer Lett. 1996 Oct 22;107(2):277-84.

PMID: 8947525 [PubMed - indexed for MEDLINE]

9:

Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.

Bouchard V, Demers MJ, Thibodeau S, Laquerre V, Fujita N, Tsuruo T, Beaulieu JF, Gauthier R, Vézina A, Villeneuve L, Vachon PH.

J Cell Physiol. 2007 Sep;212(3):717-28.

PMID: 17443665 [PubMed - indexed for MEDLINE]

10:

Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.

Kwon DS, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK.

Eur J Cell Biol. 2006 Nov;85(11):1189-99. Epub 2006 Jul 24.

PMID: 16860436 [PubMed - indexed for MEDLINE]

11:

Characterization of the biological activity of gamma-glutamyl-Se-methylselenocysteine: a novel, naturally occurring anticancer agent from garlic.

Dong Y, Lisk D, Block E, Ip C.

Cancer Res. 2001 Apr 1;61(7):2923-8.

PMID: 11306469 [PubMed - indexed for MEDLINE]

12:

Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.

Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ.

Eur J Pharmacol. 2007 Jun 1;563(1-3):49-60. Epub 2007 Feb 8.

PMID: 17341418 [PubMed - indexed for MEDLINE]

13:

Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.

Kim A, Liu B, Ordonez-Ercan D, Alvarez KM, Jones LD, McKimmey C, Edgerton SM, Yang X, Thor AD.

Breast Cancer Res. 2005;7(5):R708-18. Epub 2005 Jul 6.

PMID: 16168116 [PubMed - indexed for MEDLINE]

14:

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C.

Cancer Res. 2006 Dec 15;66(24):11851-8.

PMID: 17178882 [PubMed - indexed for MEDLINE]

15:

Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).

Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC.

Prostate. 2006 Jul 1;66(10):1070-5.

PMID: 16637076 [PubMed - indexed for MEDLINE]

17:

Extracellular acidosis induces neutrophil activation by a mechanism dependent on activation of phosphatidylinositol 3-kinase/Akt and ERK pathways.

Martínez D, Vermeulen M, Trevani A, Ceballos A, Sabatté J, Gamberale R, Alvarez ME, Salamone G, Tanos T, Coso OA, Geffner J.

J Immunol. 2006 Jan 15;176(2):1163-71.

PMID: 16394005 [PubMed - indexed for MEDLINE]

18:

Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.

Lee M.

Biochem Biophys Res Commun. 2006 Nov 17;350(2):450-6. Epub 2006 Sep 22.

PMID: 17010316 [PubMed - indexed for MEDLINE]

19:

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M.

Adv Enzyme Regul. 2006;46:249-79. Epub 2006 Jul 18.

PMID: 16854453 [PubMed - indexed for MEDLINE]

20:

Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells.

Ye J, Li A, Liu Q, Wang X, Zhou J.

Clin Exp Pharmacol Physiol. 2005 Dec;32(12):1042-8.

PMID: 16445569 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 183
of 10Next